Adult Polycystic Kidney Disease and Critical Illness Insurance
From MaRDI portal
Publication:5715913
DOI10.1080/10920277.2003.10596092zbMath1084.62531OpenAlexW2078740257MaRDI QIDQ5715913
Cristina Gutiérrez, Angus S. Macdonald
Publication date: 5 January 2006
Published in: North American Actuarial Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10920277.2003.10596092
Related Items
The impact of known breast cancer polygenes on critical illness insurance ⋮ A simulation study for multifactorial genetic disorders to quantify the impact of polygenic risk scores on critical illness insurance ⋮ Premium rates based on genetic studies: How reliable are they? ⋮ Genetics and Insurance: What have we Learned So Far? ⋮ The Impact of Multifactorial Genetic Disorders on Critical Illness Insurance: A Simulation Study Based on UK Biobank ⋮ Sampling Distributions of Critical Illness Insurance Premium Rates: Breast and Ovarian Cancer ⋮ Adult Polycystic Kidney Disease and Insurance
Cites Work